
{
    "credit": [
        {
            "email": "benjamin.haibe.kains@utoronto.ca",
            "name": "Benjamin Haibe-Kains",
            "typeEntity": "Person",
            "typeRoles": [
                "Primary contact"
            ]
        }
    ],
    "documentation": [
        {
            "type": "User manual",
            "url": "http://bioconductor.org/packages/release/bioc/html/PharmacoGx.html"
        }
    ],
    "download": [
        {
            "type": "Source code",
            "url": "http://bioconductor/packages/release/bioc/src/contrib/PharmacoGx_1.4.2.tar.gz"
        }
    ],
    "function": [
        {
            "operation": [
                {
                    "term": "Sequence analysis",
                    "uri": "http://edamontology.org/operation_2403"
                }
            ]
        }
    ],
    "labels": {
        "collectionID": [
            "BioConductor"
        ],
        "language": [
            "R"
        ],
        "license": "Artistic-2.0",
        "operatingSystem": [
            "Linux",
            "Windows",
            "Mac"
        ],
        "toolType": [
            "Command-line tool",
            "Library"
        ],
        "topic": [
            {
                "term": "Pharmacogenomics",
                "uri": "http://edamontology.org/topic_0208"
            },
            {
                "term": "Genomics",
                "uri": "http://edamontology.org/topic_0622"
            },
            {
                "term": "Pharmacology",
                "uri": "http://edamontology.org/topic_0202"
            }
        ]
    },
    "publication": [
        {
            "abstract": "Â© 2015 The Author. All rights reserved. Pharmacogenomics holds great promise for the development of biomarkers of drug response and the design of new therapeutic options, which are key challenges in precision medicine. However, such data are scattered and lack standards for efficient access and analysis, consequently preventing the realization of the full potential of pharmacogenomics. To address these issues, we implemented PharmacoGx, an easy-to-use, open source package for integrative analysis of multiple pharmacogenomic datasets. We demonstrate the utility of our package in comparing large drug sensitivity datasets, such as the Genomics of Drug Sensitivity in Cancer and the Cancer Cell Line Encyclopedia. Moreover, we show how to use our package to easily perform Connectivity Map analysis. With increasing availability of drug-related data, our package will open new avenues of research for meta-analysis of pharmacogenomic data.",
            "authors": [
                "Smirnov P.",
                "Safikhani Z.",
                "El-Hachem N.",
                "Wang D.",
                "She A.",
                "Olsen C.",
                "Freeman M.",
                "Selby H.",
                "Gendoo D.M.A.",
                "Grossmann P.",
                "Beck A.H.",
                "Aerts H.J.W.L.",
                "Lupien M.",
                "Goldenberg A.",
                "Haibe-Kains B."
            ],
            "cit_count": 30,
            "doi": "10.1093/bioinformatics/btv723",
            "journal": "Bioinformatics",
            "pmid": "26656004",
            "title": "PharmacoGx: An R package for analysis of large pharmacogenomic datasets",
            "type": "Primary",
            "year": "2016-04-15"
        }
    ],
    "summary": {
        "biotoolsCURIE": "biotools:pharmacogx",
        "biotoolsID": "pharmacogx",
        "description": "Set of functions to perform large-scale analysis of pharmacogenomic data.",
        "homepage": "http://bioconductor.org/packages/release/bioc/html/PharmacoGx.html",
        "name": "PharmacoGx",
        "version": [
            "1.4.2"
        ]
    }
}